Table of contents

Clinical and epidemiological research

• Extended report: Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study (3 September, 2015) Free

  D A Isenberg, M Petri, K Kalunian, Y Tanaka, M B Urowitz, R W Hoffman, M Morgan-Cox, N Iikuni, M Silk, D J Wallace
• Extended report: Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study (20 August, 2015) Free

  J T Merrill, R F van Vollenhoven, J P Buyon, R A Furie, W Stohl, M Morgan-Cox, C Dickson, P W Anderson, C Lee, P-Y Berclaz, T Dörner
• Extended report: Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration (21 January, 2015)

  Iris Navarro-Millán, Shuo Yang, Scott L DuVall, Lang Chen, John Baddley, Grant W Cannon, Elizabeth S Delzell, Jie Zhang, Monika M Safford, Nivedita M Patkar, Ted R Mikuls, Jasvinder A Singh, Jeffrey R Curtis
• Extended report: Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients (28 November, 2014)

  P Brito-Zerón, B Kostov, R Solans, G Fraile, C Suárez-Cuervo, A Casanovas, F J Rascón, R Qanneta, R Pérez-Alvarez, M Ripoll, M Akasbi, B Pinilla, J A Bosch, J Nava-Mateos, B Díaz-López, M L Morera-Morales, H Gheitasi, S Retamozo, M Ramos-Casals
• Extended report: Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial (30 December, 2014)

  Alf Kastbom, Kristina Forslind, Sofia Ernestam, Pierre Geborek, Johan A Karlsson, Ingemar F Petersson, Saedis Saevarsdottir, Lars Klareskog, Ronald F van Vollenhoven, Karin Lundberg
• Extended report: Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment (4 December, 2014)

  Lakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, John J Dutton, Richard Fitzgerald, Michael C Briggs, Helen Bygott, Eftychia E Psarelli, Trevor F Cox, James A Gallagher, Jonathan C Jarvis, Christa van Kan, Anthony K Hall, Dinny Laan, Birgitta Olsson, Johan Szamosi, Mattias Rudebeck, Torbjörn Kullenberg, Arvid Cronlund, Lennart Svensson, Carin Junestrand, Hana Ayoob, Oliver G Timmis, Nicolas Sireau, Kim-Hanh Le Quan Sang, Federica Genovese, Daniela Braconi, Annalisa Santucci, Martina Nemethova, Andrea Zatkova, Judith McCaffrey, Peter Christensen, Gordon Ross, Richard Imrich, Jozef Rovensky
• Extended report: The offspring of people with a total knee replacement for severe primary knee osteoarthritis have a higher risk of worsening knee pain over 8 years (4 December, 2014)

  Feng Pan, Changhai Ding, Tania Winzenberg, Hussain Khan, Johanne Martel-Pelletier, Jean-Pierre Pelletier, Flavia Cicuttini, Graeme Jones
• Extended report: Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis (1 December, 2014)

  Donald P Tashkin, Elizabeth R Volkmann, Chi-Hong Tseng, Hyun J Kim, Jonathan Goldin, Philip Clements, Daniel Furst, Dinesh Khanna, Eric Kleerup, Michael D Roth, Robert Elashoff
• Extended report: Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI) (5 December, 2014)

  Raphaèle Seror, Hendrika Bootsma, Alain Saraux, Simon J Bowman, Elke Theander, Johan G Brun, Gabriel Baron, Véronique Le Guern, Valérie Devauchelle-Pensec, Manel Ramos-Casals, Valeria Valim, Thomas Dörner, Athanasios Tzioufas, Jacques-Eric Gottenberg, Roser Solans Laqué, Thomas Mandl, Eric Hachulla, Kathy L Sivils, Wan-Fai Ng, Anne-Laure Fauchais, Stefano Bombardieri, Roberta Priori, Elena Bartoloni, Vincent Goeb, Sonja Praprotnik, Takayuki Sumida, Sumusu Nishiyama, Roberto Caporali, Aike A Kruize, Cristina Vollenweider, Philippe Ravaud, Petra Meiners, Pilar Brito-Zerón, Claudio Vitali, Xavier Mariette
• Extended report: Synovitis in knee osteoarthritis: a precursor of disease? (8 December, 2014)

  I Atukorala, C K Kwoh, A Guermazi, F W Roemer, R M Boudreau, M J Hannon, D J Hunter
• Extended report: Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (2 December, 2014)

  A J Mohammad, A Hot, F Arndt, F Moosig, M-J Guerry, N Amudala, R Smith, P Sivasothy, L Guillevin, P A Merkel, D R W Jayne
• Extended report: Global ultrasound assessment of structural lesions in osteoarthritis: a reliability study by the OMERACT ultrasonography group on scoring cartilage and osteophytes in finger joints (17 December, 2014)

  H B Hammer, A Iagnocco, A Mathiessen, E Filippucci, F Gandjbakhch, M C Kortekaas, I Möller, E Naredo, R J Wakefield, P Aegerter, M-A D'Agostino
• Concise report: Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study (6 August, 2015)

  Xenofon Baraliakos, Babul Borah, Juergen Braun, Dominique Baeten, Didier Laurent, Joachim Sieper, Paul Emery, Iain B McInnes, Jacob M van Laar, Paul Wordsworth, Juergen Wollenhaupt, Herbert Kellner, Laurence Colin, Francois Vandenhende, Kath Radford, Wolfgang Hueber